{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:52:50Z","timestamp":1791381170780,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanchong City School Cooperation Research Project","award":["19SXHZ0429"],"award-info":[{"award-number":["19SXHZ0429"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05560-6","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:34:20Z","timestamp":1783931660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interpretable model based on unenhanced MRI radiomics and clinical features for the identification of HER2 expression in breast cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Mengyi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3490-4142","authenticated-orcid":false,"given":"Xiaohua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"1","key":"5560_CR1","first-page":"12","volume":"74","author":"R Siegel","year":"2024","unstructured":"Siegel R, Giaquinto A, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5560_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000524227","volume":"89","author":"D Grassini","year":"2022","unstructured":"Grassini D, Cascardi E, Sarotto I, Annaratone L, Sapino A, Berrino E, Marchi\u00f2 C. Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives. Pathobiology. 2022;89(5):278\u201396.","journal-title":"Pathobiology"},{"issue":"17","key":"5560_CR3","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.3390\/cancers15174336","volume":"15","author":"D Mata","year":"2023","unstructured":"Giffoni de Mello Morais, Mata D, Chehade R, Hannouf MB, Raphael J, Blanchette P et al. Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer-A Literature Review. Cancers (Basel). 2023;15(17):4336.","journal-title":"Cancers (Basel)"},{"key":"5560_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/tbcr-23-48","volume":"5","author":"Q Wu","year":"2024","unstructured":"Wu Q, Xu L. Challenges in HER2-low breast cancer identification, detection, and treatment. Transl Breast Cancer Res. 2024;5:3.","journal-title":"Transl Breast Cancer Res"},{"issue":"5","key":"5560_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1200\/JCO.19.01455","volume":"38","author":"L Fehrenbacher","year":"2020","unstructured":"Fehrenbacher L, Cecchini RS, Geyer CEJ, Rastogi P, Costantino JP, Atkins JN et al. NSABP B-47\/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1\u2009+\u2009or 2. J Clin Oncol. 2020;38(5):444\u201353.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5560_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/cco-20-123","volume":"9","author":"M Takada","year":"2020","unstructured":"Takada M, Toi M. Neoadjuvant treatment for HER2-positive breast cancer. Chin Clin Oncol. 2020;9(3):32.","journal-title":"Chin Clin Oncol"},{"issue":"17","key":"5560_CR7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1200\/JCO.19.02318","volume":"38","author":"S Modi","year":"2020","unstructured":"Modi S, Park H, Murthy RK, Iwata H, Tamura K, Tsurutani J et al. Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study. J Clin Oncol. 2020;38(17):1887\u201396.","journal-title":"J Clin Oncol"},{"issue":"7","key":"5560_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/cac2.12577","volume":"44","author":"J Wang","year":"2024","unstructured":"Wang J, Liu Y, Zhang Q, Li W, Feng J, Wang X, Fang J, Han Y, Xu B. Disitamab vedotin, a HER2-directed antibody-drug conjugate, in patients with HER2-overexpression and HER2-low advanced breast cancer: a phase I\/Ib study. Cancer Commun (Lond). 2024;44(7):833\u201351.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"5560_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66\u201396.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"5560_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41598-024-51630-6","volume":"14","author":"S Kim","year":"2024","unstructured":"Kim S, Lim JH, Kim CH, Roh J, You S, Choi JS et al. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients. Sci Rep. 2024;14(1):922.","journal-title":"Sci Rep"},{"issue":"12","key":"5560_CR11","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/diagnostics13121996","volume":"13","author":"A Rotili","year":"2023","unstructured":"Rotili A, Pesapane F, Signorelli G, Penco S, Nicosia L, Bozzini A et al. An Unenhanced Breast MRI Protocol Based on Diffusion-Weighted Imaging: A Retrospective Single-Center Study on High-Risk Population for Breast Cancer. Diagnostics (Basel). 2023;13(12):1996.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"5560_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.21846","volume":"42","author":"J Guiot","year":"2022","unstructured":"Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix AN et al. A review in radiomics: Making personalized medicine a reality via routine imaging. Med Res Rev. 2022;42(1):426\u201340.","journal-title":"Med Res Rev"},{"issue":"7","key":"5560_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/1754-9485.13581","volume":"67","author":"P Sharma","year":"2023","unstructured":"Sharma P, Cheng J, Coulthard A. Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium. J Med Imaging Radiat Oncol. 2023;67(7):742\u201352.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"5560_CR14","doi-asserted-by":"publisher","first-page":"113259","DOI":"10.1016\/j.marpolbul.2021.113259","volume":"174","author":"K Inoue","year":"2022","unstructured":"Inoue K, Fukushi M, Sahoo SK, Veerasamy N, Furukawa A, Soyama S et al. Measurements and future projections of Gd-based contrast agents for MRI exams in wastewater treatment plants in the Tokyo metropolitan area. Mar Pollut Bull. 2022;174:113259.","journal-title":"Mar Pollut Bull"},{"issue":"10","key":"5560_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.acra.2020.05.040","volume":"28","author":"J Zhou","year":"2021","unstructured":"Zhou J, Tan H, Li W, Liu Z, Wu Y, Bai Y, Fu F, Jia X, Feng A, Liu H, Wang M. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer. Acad Radiol. 2021;28(10):1352\u201360.","journal-title":"Acad Radiol"},{"issue":"5","key":"5560_CR16","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/jmri.28628","volume":"58","author":"X Bian","year":"2023","unstructured":"Bian X, Du S, Yue Z, Gao S, Zhao R, Huang G, Guo L, Peng C, Zhang L. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer. J Magn Reson Imaging. 2023;58(5):1603\u201314.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"5560_CR17","doi-asserted-by":"publisher","first-page":"e222646","DOI":"10.1148\/radiol.222646","volume":"308","author":"T Ramtohul","year":"2023","unstructured":"Ramtohul T, Djerroudi L, Lissavalid E, Nhy C, Redon L, Ikni L et al. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers. Radiology. 2023;308(2):e222646.","journal-title":"Radiology"},{"issue":"5","key":"5560_CR18","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.21037\/qims-23-1700","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Ao Y, Mu L, Wang C, Zhao J, Chen H, Zhang S, Yang S, Zhang N, Qiu L. Effect of contrast agent on T2-weighted fat-suppressed imaging and diffusion-weighted imaging in the diagnosis of breast tumors. Quant Imaging Med Surg. 2024;14(5):3655\u201364.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"5560_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s12885-022-09967-6","volume":"22","author":"A Xu","year":"2022","unstructured":"Xu A, Chu X, Zhang S, Zheng J, Shi D, Lv S, Li F, Weng X. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma. BMC Cancer. 2022;22(1):872.","journal-title":"BMC Cancer"},{"issue":"10","key":"5560_CR20","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.acra.2020.05.040","volume":"28","author":"J Zhou","year":"2022","unstructured":"Zhou J, Tan H, Li W, Liu Z, Wu Y, Bai Y et al. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer. Acad Radiol. 2022;28(10):1352\u201360.","journal-title":"Acad Radiol"},{"issue":"9","key":"5560_CR21","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1007\/s00330-024-10641-7","volume":"34","author":"S Zheng","year":"2024","unstructured":"Zheng S, Yang Z, Du G, Zhang Y, Jiang C, Xu T et al. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics. Eur Radiol. 2024;34(9):6132\u201344.","journal-title":"Eur Radiol"},{"issue":"1","key":"5560_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/cancers16010203","volume":"16","author":"G Nicoletti","year":"2024","unstructured":"Nicoletti G, Mazzetti S, Maimone G, Cignini V, Cuocolo R, Faletti R et al. Development and Validation of an Explainable Radiomics Model to Predict High-Aggressive Prostate Cancer: A Multicenter Radiomics Study Based on Biparametric MRI. Cancers (Basel). 2024;16(1):203.","journal-title":"Cancers (Basel)"},{"issue":"22","key":"5560_CR23","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, McShane LM et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO\u2013College of American Pathologists Guideline Update. J Clin Oncol. 2023;41(22):3867\u201372.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5560_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/AJR.20.25223","volume":"217","author":"DC Teichgraeber","year":"2021","unstructured":"Teichgraeber DC, Guirguis MS, Whitman GJ. Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual, 8th Edition, and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol. 2021;217(2):278\u201390.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5560_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12282-014-0572-9","volume":"22","author":"T Uematsu","year":"2015","unstructured":"Uematsu T. Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema. Breast Cancer. 2015;22(1):66\u201370.","journal-title":"Breast Cancer"},{"issue":"6","key":"5560_CR26","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1007\/s00330-020-06662-7","volume":"30","author":"TL Harada","year":"2020","unstructured":"Harada TL, Uematsu T, Nakashima K, Sugino T, Nishimura S, Takahashi K et al. Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer? Eur Radiol. 2020;30(6):3363\u201370.","journal-title":"Eur Radiol"},{"issue":"5","key":"5560_CR27","first-page":"453","volume":"172","author":"L Tuan Linh","year":"2021","unstructured":"Tuan Linh L, Minh Duc N, Tra My TT, Viet Bang L, Minh Thong P. Correlations between dynamic contrast-enhanced magnetic resonance imaging parameters and histopathologic factors in breast cancer. Clin Ter. 2021;172(5):453\u201360.","journal-title":"Clin Ter"},{"issue":"3","key":"5560_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","volume":"98","author":"DA Spak","year":"2017","unstructured":"Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE. BI-RADS\u00ae fifth edition: A summary of changes. Diagn Interv Imaging. 2017;98(3):179\u201390.","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"5560_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jmri.29149","volume":"60","author":"L Zhang","year":"2024","unstructured":"Zhang L, Shen M, Zhang D, He X, Du Q, Liu N, Huang X. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer. J Magn Reson Imaging. 2024;60(3):1203\u201312.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"5560_CR30","doi-asserted-by":"publisher","first-page":"e3169","DOI":"10.1016\/j.crad.2020.12.013","volume":"76","author":"C Ma","year":"2021","unstructured":"Ma C, Hui Q, Gao X, Xu D, Tang B, Pen M, Lui S, Chen X. The feasibility of dual-energy CT to predict the probability of symptomatic intracerebral haemorrhage after successful mechanical thrombectomy. Clin Radiol. 2021;76(4):e3169\u2013316.","journal-title":"Clin Radiol"},{"issue":"6","key":"5560_CR31","doi-asserted-by":"publisher","first-page":"C1359","DOI":"10.1152\/ajpcell.00054.2024","volume":"327","author":"S Aburahess","year":"2024","unstructured":"Aburahess S, Li L, Hussain A, Obeidat M, Alavi P, Azad AK, Jahroudi N, Ballermann B. Hypoxia-induced TIMAP upregulation in endothelial cells and TIMAP-dependent tumor angiogenesis. Am J Physiol Cell Physiol. 2024;327(6):C1359\u201372.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"5560_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0959-8049(03)00673-7","volume":"40","author":"B Linderholm","year":"2004","unstructured":"Linderholm B, Andersson J, Lindh B, Beckman L, Erlanson M, Edin K et al. Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment. Eur J Cancer. 2004;40(1):33\u201342.","journal-title":"Eur J Cancer"},{"issue":"1","key":"5560_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13244-023-01424-7","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wang L, Luo R, Liu H, Zhang Y, Wang D. Focal breast edema and breast edema score on T2-weighted images provides valuable biological information for invasive breast cancer. Insights Imaging. 2023;14(1):73.","journal-title":"Insights Imaging"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05560-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:03:11Z","timestamp":1791378191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05560-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5560"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05560-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was granted by the Ethics Committee of Affiliated Hospital of North Sichuan Medical College (No. 2025ER7-1). The requirement for informed consent was formally waived by the Affiliated Hospital of North Sichuan Medical College. This study was performed in line with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1410"}}